Department of Physical Therapy and Rehabilitation Science Department, Roy J and Lucille A Carver College of Medicine, The University of Iowa, Iowa City, IA 52242, USA.
Department of Physical Therapy, St. Ambrose University, Davenport, IA 52803, USA.
Medicina (Kaunas). 2022 Sep 22;58(10):1332. doi: 10.3390/medicina58101332.
Transcutaneous electrical nerve stimulation (TENS) is a non-pharmacological intervention used in the treatment of acute and chronic pain conditions. The first clinical studies on TENS were published over 50 years ago, when effective parameters of stimulation were unclear and clinical trial design was in its infancy. Over the last two decades, a better understanding of the mechanisms underlying TENS efficacy has led to the development of an adequate dose and has improved outcome measure utilization. The continued uncertainty about the clinical efficacy of TENS to alleviate pain, despite years of research, is related to the quality of the clinical trials included in systematic reviews. This summary of the evidence includes only trials with pain as the primary outcome. The outcomes will be rated as positive (+), negative (-), undecided (U), or equivalent to other effective interventions (=). In comparison with our 2014 review, there appears to be improvement in adverse events and parameter reporting. Importantly, stimulation intensity has been documented as critical to therapeutic success. Examinations of the outcomes beyond resting pain, analgesic tolerance, and identification of TENS responders remain less studied areas of research. This literature review supports the conclusion that TENS may have efficacy for a variety of acute and chronic pain conditions, although the magnitude of the effect remains uncertain due to the low quality of existing literature. In order to provide information to individuals with pain and to clinicians treating those with pain, we suggest that resources for research should target larger, high-quality clinical trials including an adequate TENS dose and adequate timing of the outcome and should monitor risks of bias. Systematic reviews and meta-analyses should focus only on areas with sufficiently strong clinical trials that will result in adequate sample size.
经皮神经电刺激(TENS)是一种非药物干预手段,用于治疗急性和慢性疼痛病症。TENS 的首次临床研究发表于 50 多年前,当时刺激的有效参数尚不清楚,临床试验设计也处于起步阶段。在过去的二十年中,人们对 TENS 疗效机制的理解有所加深,这导致了适当剂量的发展,并改进了结果测量的应用。尽管经过多年的研究,TENS 缓解疼痛的临床疗效仍然存在持续的不确定性,这与系统评价中纳入的临床试验质量有关。本证据总结仅包括以疼痛为主要结局的试验。结果将被评为阳性(+)、阴性(-)、不确定(U)或等同于其他有效干预(=)。与我们 2014 年的综述相比,不良事件和参数报告似乎有所改善。重要的是,刺激强度已被证明是治疗成功的关键。对于疼痛缓解之外的结果以及对 TENS 应答者的识别的研究仍然较少。本文献综述支持 TENS 可能对各种急性和慢性疼痛病症有效这一结论,尽管由于现有文献质量较低,其疗效的幅度仍不确定。为了向疼痛患者和治疗疼痛患者的临床医生提供信息,我们建议将研究资源用于针对具有足够大样本量的高质量临床试验,包括适当的 TENS 剂量和结果的适当时间,并监测偏倚风险。系统评价和荟萃分析应仅关注具有足够强临床试验的领域,这些领域将产生足够大的样本量。
Medicina (Kaunas). 2022-9-22
Cochrane Database Syst Rev. 2019-4-3
Cochrane Database Syst Rev. 2019-2-19
Cochrane Database Syst Rev. 2020-3-3
Cochrane Database Syst Rev. 2022-2-1
Cochrane Database Syst Rev. 2017-9-14
Cochrane Database Syst Rev. 2001
Cochrane Database Syst Rev. 2019-12-12
Cochrane Database Syst Rev. 2008-7-16
Front Pain Res (Lausanne). 2025-8-18
Physiother Res Int. 2025-10
Front Pain Res (Lausanne). 2025-6-17
Front Pain Res (Lausanne). 2025-4-17
J Orthop Sports Phys Ther. 2021-2